Catheter ablation improves cardiovascular outcomes in patients with atrial fibrillation and heart failure: a meta-analysis of randomized controlled trials
Authors:
- Florentina A SimaderFSFlorentina A Simader
- James P HowardJHJames P Howard
- Yousif AhmadYAYousif Ahmad
- Keenan SalehKSKeenan Saleh
- Akriti NaraenANAkriti Naraen
- Jack W SamwaysJSJack W Samways
- Rohin K ReddyRRRohin K Reddy
- Nandita KazaNKNandita Kaza
- Daniel KeeneDKDaniel Keene
- Matthew J Shun-ShinMSMatthew J Shun-Shin
- Darrel P FrancisDFDarrel P Francis
Open Access
- 28 October 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 25 (2) , 341-350
Abstract
The effect of atrial fibrillation catheter ablation on cardiovascular outcomes in heart failure is an important outstanding research question. We undertook a meta-analysis of randomized controlled trials comparing ablation to medical therapy in patients with AF and heart failure. We systematically identified all trials comparing catheter ablation to medical therapy in patients with heart failure and atrial fibrillation. The pre-specified primary endpoint was all-cause mortality in trials with at least 2 years of follow-up. The secondary endpoint was heart failure hospitalization. Sensitivity analyses were performed for trials with any follow-up and trials deemed at low risk of bias. Eight trials (1390 patients) were included. Seven hundred and seven patients were randomized to catheter ablation and 683 to medical therapy. In the primary analysis (three trials, n = 977), catheter ablation reduced mortality compared with medical therapy [relative risk (RR): 0.61, 95% confidence interval (CI): 0.44 to 0.84, P = 0.003]. Catheter ablation also reduced heart failure hospitalizations compared with medical therapy (RR: 0.60, 95% CI: 0.49–0.74, P < 0.001). The effect on stroke was not statistically significant (RR: 0.62, 95% CI: 0.28–1.37, P = 0.237). There was low heterogeneity between studies. Sensitivity analyses were consistent with the primary analyses. In patients with atrial fibrillation and heart failure, catheter ablation reduces mortality and the occurrence of heart failure hospitalizations.Keywords
Funding Information
- British Heart Foundation (BHF, FS/CRTF/21/24171)
- Imperial BHF Centre of Research Excellence (RE/18/4/34215)
This publication has 22 references indexed in Scilit:
- Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted DeviceCirculation, 2016
- A Randomized Controlled Trial of Catheter Ablation Versus Medical Treatment of Atrial Fibrillation in Heart Failure (The CAMTAF Trial)Circulation: Arrhythmia and Electrophysiology, 2014
- A Randomized Trial to Assess Catheter Ablation Versus Rate Control in the Management of Persistent Atrial Fibrillation in Heart FailureJACC, 2013
- Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial FibrillationJACC, 2013
- Long‐term Outcomes of Catheter Ablation of Atrial Fibrillation: A Systematic Review and Meta‐analysisJournal of the American Heart Association, 2013
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trialHeart, 2010
- Pulmonary-Vein Isolation for Atrial Fibrillation in Patients with Heart FailureNew England Journal of Medicine, 2008
- Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on MortalityCirculation, 2003
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002